GlaxoSmithKline – Interim Target A

Emissions reduction target
by
2025
Description of Interim Target

Our Scope 1 and 2 SBTI-accredited target aims for a 34% by 2025 from a 2017 baseline.

  • Interim Target Baseline Year: 2017
% reductions committed to
34
Interim Target
Emissions reduction target
Baseline Emissions

Sign up for Net-Zero Portal Office Hours!

Schedule a call with us to receive a free demo of the Net-Zero Portal and learn how we can support your organization’s net-zero goals.

Net-Zero Portal © 2025

Website by SeriousOtters